BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7567062)

  • 1. Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens.
    Jansen HJ; Grenier D; Van der Hoeven JS
    Oral Microbiol Immunol; 1995 Jun; 10(3):138-45. PubMed ID: 7567062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the use of SDS-PAGE of cell surface extracts and proteolytic activity to differentiate Prevotella nigrescens and Prevotella intermedia.
    Cookson AL; Wray A; Handley PS; Jacob AE
    FEMS Microbiol Lett; 1996 Feb; 136(2):109-15. PubMed ID: 8869494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein degradation by Prevotella intermedia and Actinomyces meyeri supports the growth of non-protein-cleaving oral bacteria in serum.
    Jansen HJ; van der Hoeven JS
    J Clin Periodontol; 1997 May; 24(5):346-53. PubMed ID: 9178115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolytic and depolymerising enzyme activity of Prevotella intermedia and Prevotella nigrescens.
    Stubbs S; Lewis MA; Waddington RJ; Embery G
    Oral Dis; 1996 Dec; 2(4):272-8. PubMed ID: 9171510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum.
    Frandsen EV; Kjeldsen M; Kilian M
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):458-64. PubMed ID: 9220164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase activity of prevotella species associated with oral purulent infection.
    Yanagisawa M; Kuriyama T; Williams DW; Nakagawa K; Karasawa T
    Curr Microbiol; 2006 May; 52(5):375-8. PubMed ID: 16586023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.
    Collin M; Olsén A
    Infect Immun; 2001 Nov; 69(11):7187-9. PubMed ID: 11598100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of Prevotella nigrescens and Prevotella intermedia in infections of endodontic origin.
    Bae KS; Baumgartner JC; Shearer TR; David LL
    J Endod; 1997 Oct; 23(10):620-3. PubMed ID: 9587274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of the species Prevotella intermedia and Prevotella nigrescens.
    Frandsen EV; Poulsen K; Kilian M
    Int J Syst Bacteriol; 1995 Jul; 45(3):429-35. PubMed ID: 8590668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the human immunoglobulin G Fc-binding activity in Prevotella intermedia.
    Labbé S; Grenier D
    Infect Immun; 1995 Jul; 63(7):2785-9. PubMed ID: 7790101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucose on formation of cytotoxic end-products and proteolytic activity of Prevotella intermedia, Prevotella nigrescens and Porphyromonas gingivalis.
    Saito K; Takahashi N; Horiuchi H; Yamada T
    J Periodontal Res; 2001 Dec; 36(6):355-60. PubMed ID: 11762870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and polymerase chain reaction for differentiation of Prevotella intermedia and Prevotella nigrescens.
    Baumgartner JC; Bae KS; Xia T; Whitt J; David LL
    J Endod; 1999 May; 25(5):324-8. PubMed ID: 10530254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activation of the hemolysin in Prevotella nigrescens ATCC 33563 and Prevotella intermedia ATCC 25611.
    Silva TA; Noronha FS; de Macêdo Farias L; Carvalho MA
    Res Microbiol; 2004; 155(1):31-8. PubMed ID: 14759706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of immunoglobulin G by periodontal bacteria.
    Jansen HJ; van der Hoeven JS; van den Kieboom CW; Göertz JH; Camp PJ; Bakkeren JA
    Oral Microbiol Immunol; 1994 Dec; 9(6):345-51. PubMed ID: 7870469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human B-lymphocytes by Prevotella intermedia.
    Homayounfar A; Bergström J; Hammarström L
    Swed Dent J; 1999; 23(1):11-5. PubMed ID: 10371001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases.
    Grønbaek Frandsen EV
    APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and utilization of human transferrin by Prevotella nigrescens.
    Duchesne P; Grenier D; Mayrand D
    Infect Immun; 1999 Feb; 67(2):576-80. PubMed ID: 9916061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and genetic characterization of a Prevotella intermedia/nigrescens-like organism.
    Könönen E; Mättö J; Väisänen-Tunkelrott ML; Frandsen EV; Helander I; Asikainen S; Finegold SM; Jousimies-Somer H
    Int J Syst Bacteriol; 1998 Jan; 48 Pt 1():39-46. PubMed ID: 9542074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Prevotella intermedia and Prevotella nigrescens by enzyme production, restriction endonuclease and ribosomal RNA gene restriction analyses.
    Pearce MA; Dixon RA; Gharbia SE; Shah HN; Devine DA
    Oral Microbiol Immunol; 1996 Jun; 11(3):135-41. PubMed ID: 8941766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure.
    Madianos PN; Lieff S; Murtha AP; Boggess KA; Auten RL; Beck JD; Offenbacher S
    Ann Periodontol; 2001 Dec; 6(1):175-82. PubMed ID: 11887461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.